Document is current

Any future updates will be listed below

Retraction Note: Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis

Crossref DOI link: https://doi.org/10.1038/s41416-025-03214-y

Published Online: 2025-09-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark